A post hoc comparison of levodopa-carbidopa intestinal gel daytime monotherapy vs polytherapy safety and efficacy in patients with advanced Parkinson's disease: Results from 6 phase 3/3b open-label studies

A post hoc comparison of levodopa-carbidopa intestinal gel daytime monotherapy vs polytherapy safety and efficacy in patients with advanced Parkinson's disease: Results from 6 phase 3/3b open-label studies

Introduction: As Parkinson's disease (PD) progresses, the number/frequency of PD medications tend to increase, which is correlated with decreased patient compliance and suboptimal control of PD symptoms. We investigated efficacy and safety of levodopa-carbidopa intestinal gel (LCIG) daytime mon...

Full description

Bibliographic Details
Main Authors: James T. Boyd, Cindy Zadikoff, Janet A. Benesh, Jorge Zamudio, Weining Z. Robieson, Pavnit Kukreja, Masayuki Yokoyama, Mustafa S. Siddiqui
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Clinical Parkinsonism & Related Disorders
Subjects:
LCIG
Levodopa
Monotherapy
Parkinson's disease
Online Access:http://www.sciencedirect.com/science/article/pii/S2590112519300325

Internet

http://www.sciencedirect.com/science/article/pii/S2590112519300325

Similar Items